Singapūra - angļu - HSA (Health Sciences Authority)

thermo scientific microbiology pte ltd - microbiology - brucella agglutinating sera (brucella abortus and brucella melitensis) are intended for use in quantitative tube agglutination tests for serological identification of brucella cultures for epidemiological and diagnostic purposes. they may also be used as control antisera for stained brucella suspensions (ss14/30855501 and ss15/30953501). antisera provide serological identification only; full identification of an organism must only be made in conjunction with biochemical testing.

Singapūra - angļu - HSA (Health Sciences Authority)

thermo scientific microbiology pte ltd - microbiology - stained brucella suspensions are used to detect, identify and quantitate specific antibodies to brucella abortus and brucella melitensis in sera. they are standardised, smooth suspensions of killed bacteria which have been stained to facilitate reading of agglutination tests. stained brucella suspensions are used primarily in the investigation of pyrexia, and are suitable for use in standard widal tests.

Singapūra - angļu - HSA (Health Sciences Authority)

premier diagnostics pte. ltd. - immunology - purified dna of brucella abortus to be used to control in vitro diagnosis techniques based in nucleic acids amplification.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

nutritional specialties, inc. - aloe (unii: v5vd430yw9) (aloe - unii:v5vd430yw9), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), garlic (unii: v1v998dc17) (garlic - unii:v1v998dc17), bacillus anthracis immunoserum rabbit (unii: 41lz22dd4n) (bacillus anthracis immunoserum rabbit - unii:41lz22dd4n), clostridium tetani (unii: 751e8j54vm) (clostridium tetani - unii:751e8j54vm), brucella abortus (unii: 492lcm0tul) (brucella abortus - unii:492lcm0tul), escherichia coli (unii: 514b9k0l10) (escherichia coli - unii:514b9k0l10 - aids in temporary relief of headaches, runny nose, chills, minor cough, fatigue, and mild abdominal discomfort.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. aids in temporary relief of headaches, runny nose, chills, minor cough, fatigue, and mild abdominal discomfort.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Tanzānija - angļu - Tanzania Medicinces & Medical Devices Authority

tulip diagnostics (p) ltd , india - brucella abortus & melitensis -

Tanzānija - angļu - Tanzania Medicinces & Medical Devices Authority

phomas diagnostics and medical supplies limited, tanzania - culture media -

Filipīnas - angļu - FDA (Food And Drug Administration)

lifeline diagnostics supplies, inc.; distributor: lifeline diagnostics supplies, inc. - none - n/a - n/a

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - trimethoprim; sulfadoxine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 40.0 mg/ml; sulfadoxine sulfanyl active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - actinomyces spp. | bacillus anthracis | bacterial infection | bordetella spp. | bronchitis | brucella spp. | campylobacter spp. | clostridium spp. | corynebacterium spp. | cystitis | escherichia coli (e. coli) | fusobacterium spp. | haemophilus spp. | infections of the alimentary tract | infections of the urinary tracts | klebsiella spp. | metritis | nephritis | pasteurella spp. | pneumonia | salmonella | salmonella spp. | shigella spp. | staphylococci | streptococci | urethritis | vaginitis | wound infections | abscesses | amoxycillin sensitive bacteria | anaerobic bacteria | anthrax | associated with viral disease | bacterial canker | bacterial pneumonia | bordetella bronchiseptica | brucella abortus | brucella melitensis | brucella suis | clostridium botulinum | clostridium chauvoei | clostridium fallax | clostridium feseri | clostridium hemolyticum | clostridium novyi | clostridium perfringens types | clostridium septicum | clostridium sordelli | clostridium sporogenes | clostridium tetani | escherichia

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 115.4 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - other conditions: protect from moisture. indications: infections caused by the following organisms; mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents). borreliae (relapsing fever). calymmatobacterium (donovania) granulomatis (granuloma inguinale). infections caused by the following gram- negative microorganisms: vibrio species (chlorea), brucella sp. (brucellosis; in conjuction with streptomycin), haemophilus ducreyi (chancroid), yersinia pestis (plague), francisella turarenis (tularaemia), bartonella bacilliformis (bartonellosis), bacteroides sp. when penicillin is contraindicated, doxy-100 is an alternative drug in the treatment of infections due to: treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). doxy-100 is not the drug of choice in the treatment of any type of staphylococcal infection or infections due to streptococcus pneumoniae, haemophilus infuenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxy-100 should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis, doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example, chloroquine.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 115.4 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - infections caused by the following organisms; mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus); chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone, or in combination with topical agents). borreliae (relapsing fever). calymmatobacterium (donovania) granulomatis (granuloma inguinale). infection caused by the following gram-negative microorganisms: vibrio species (chlorea), brucella sp. (brucellosis; in conjunction with streptomycin), haemophilus ducreyi (chancroid), yersinia pestis (plague), francisella turarenis (tularaemia), bartonella bacilliformis (bartonellosis), bacteroides sp. when penicillin is contraindicated, doxy-100 is an alternative drug in the treatment of infections due to : treponema pallidum (syphilis); treponema pertenue (yaws); neisseria gonorrhoea (see dosage and administration). doxy-100 is not the drug of choice in the treatment of any type of staphylococcal infection or infections due to streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, streptococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxy-100 should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a beta-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis, doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example, chloroquine.